Results 291 to 300 of about 8,732,052 (351)

Applications of CRISPR-Cas-Based Genome Editing Approaches Against Human Cytomegalovirus Infection. [PDF]

Biomedicines
Zhang A, Zhang I, Liu F.
europepmc   +1 more source

Retraction: The Downregulation of GFI1 by the EZH2-NDY1/KDM2B-JARID2 Axis and by Human Cytomegalovirus (HCMV) Associated Factors Allows the Activation of the HCMV Major IE Promoter and the Transition to Productive Infection. [PDF]

PLoS Pathog
PLOS Pathogens Editors.
europepmc   +1 more source

Nano-Flow Cytometry-Guided Discrimination and Separation of Human Cytomegalovirus Virions and Extracellular Vesicles. [PDF]

J Extracell Vesicles
Bokun V, Strang BL, Pantazi P, Liu Y, Holder B.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Overview of Human Cytomegalovirus Pathogenesis.

Methods in molecular biology, 2021
Human cytomegalovirus (HCMV) is a betaherpesvirus with a global seroprevalence of 60-90%. HCMV is the leading cause of congenital infections and poses a great health risk to immunocompromised individuals. Although HCMV infection is typically asymptomatic in the immunocompetent population, infection can result in mononucleosis and has also been ...
Heather L. Fulkerson, Maciej T. Nogalski, Donna Collins-McMillen, A. Yurochko   +3 more
semanticscholar   +3 more sources

The human cytomegalovirus

Pharmacology & Therapeutics, 2003
Human cytomegalovirus (HCMV), a betaherpesvirus, represents the major infectious cause of birth defects, as well as an important pathogen for immunocompromised individuals. The viral nucleocapsid containing a linear double-stranded DNA of 230 kb is surrounded by a proteinaceous tegument, which is itself enclosed by a loosely applied lipid bilayer ...
LANDOLFO, Santo Giuseppe, GARIGLIO M., GRIBAUDO, Giorgio, LEMBO, David   +3 more
openaire   +2 more sources